PHAT Q4 2022 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$168,000

Operating Income

-$47M

Net Income

-$55M

EPS (Diluted)

$-1.54

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$41M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$165M

Total Liabilities

$240M

Stockholders' Equity

-$75M

Cash & Equivalents

$155M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$168,000	-$135,000	-24.4%
Operating Income	-$47M	-$33M	-41.2%
Net Income	-$55M	-$36M	-53.7%